BioNTech SE - ADR vs Open Text Corporation — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Open Text Corporation trades at $23.98 (market cap $5.80B). The key difference: BioNTech SE - ADR is far larger — about 4× Open Text Corporation's market cap, and Open Text Corporation pays a 4.67% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | OTEX | |
|---|---|---|
Market Cap | $23.31B | $5.80B |
Sector | Health | Technology |
52-Week High | $119.34 | $39.69 |
52-Week Low | $83.89 | $20.01 |
Enterprise Value | $6.60B | $10.81B |
Dividend Yield | — | 4.67% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →